Grants and Contributions

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The specific objectives of this funding opportunity are to:

• Generate high quality evidence required to optimize the RD diagnosis pathway in Canada;
• Evaluate the health outcomes associated with RDs via the ‘genomics first’ diagnosis pathway compared to the current approach (i.e., genomic testing performed later);
• Determine the economic impact to the health care system for the ‘genomics first’ diagnosis pathway and compare to current diagnostic pathways for RDs;
• Evaluate the socioeconomic and psychological impacts of delays in the diagnosis on patients/families with RDs from a diversity of population groups and communities in Canada using the ‘genomics first’ diagnostic paradigm as a comparator; and,
• Mobilize knowledge to facilitate the implementation, scale and spread of best practices for diagnosing RDs in Canada.

The specific objectives of this funding opportunity are to:

• Demonstrate the feasibility of tracking rare diseases and conducting prospective studies in this field within the Canadian health care systems;
• Increase cross-jurisdictional collaboration and data sharing amongst hospitals;
• Prospectively assess the impact of mortality, co-morbidities, hospital usage, other health system usage, and total direct cost of rare diseases to the health care system; and,
• Facilitate the establishment of patient registries for potential enrollment by a diversity of people in Canada in clinical trials and to enable patient and caregiver peer-to-peer contact.

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The Project Grant program is expected to:
• Support a diverse portfolio of health-related research and knowledge translation proposals at any stage, from discovery to application, including commercialization;
• Promote relevant collaborations across disciplines, professions, and sectors; and
• Contribute to the creation and use of health-related knowledge.

The specific objectives of this funding opportunity are to:

• Strengthen integration, uptake, deployment and/or scale-up (spread) of evidence-based solutions: Improve existing programs, services, and/or models of care including equitable and inclusive access for diverse groups of people living with cognitive impairment and dementia, and for those that care for them.
• Build capacity: Strengthen implementation science approaches informed by intersectional equity, diversity and inclusion (EDI) considerations among research teams, including early career researchers and knowledge users (i.e., PWLLE, decision makers), in cognitive impairment research

The main objectives of CCNA Phase III (Operations Centre and CCNA Research teams) align with and build upon Phases I and II:
• Increase the interdisciplinary collaborations within and across Teams, Themes and the Operations Centre in the area of age-related neurodegenerative diseases having an impact on cognition, including, but not limited to, prevention and risk reduction, diagnosis, treatment, care, services and social aspects;
• Build capacity in age-related neurodegenerative diseases that have an impact on cognition, including, but not limited to: prevention and risk reduction, diagnosis, treatment, care, services, social aspects, while recognizing, integrating and addressing equity, diversity and inclusion considerations, First Nations, Inuit and Métis health perspectives and persons with living/lived experience; and,
• Enhance the competitiveness of researchers in Canada, their international presence and influence on outcomes related to neurodegenerative diseases affecting cognition.

The specific objectives of the CCNA Operations Centre funding opportunity are to:
• Optimize a national operations centre to provide leadership, strengthen, and synergize innovative and collaborative Canadian research in neurodegenerative diseases;
• Provide guidance and coordination efforts for training and capacity development, to foster career development of the next generation of researchers in the field;
• Enhance the capacity for knowledge mobilization (KM) in both official languages to increase the dissemination and uptake of neurodegenerative diseases research results and enhance national and international research collaborations;
• Facilitate and support engagement of persons with neurodegenerative diseases affecting cognition and care partners to be actively involved throughout the research process;
• Scope and solidify CCNA’s strategic vision in line with the uniqueness of its data;
• Optimize systems and mechanisms ensuring increased awareness of, and responsible and timely access to CCNA data and biospecimens, while meeting ethical standards and protecting the privacy of participants; and,
• Enhance national and international research collaborations through data and KM linkages with other entities and/or research platforms, such as the CLSA.

Not a Project (Mandated or Core Funding)

Not a Project (Mandated or Core Funding)